Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REPEAT repeat intramyocardial autologous bone marrow cell injection for refractory angina
NL-OMON20190Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Dec 2010
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of autologous bone marrow-derived mononuclear cell in angina pectoris and cardiac ischemia, sponsored by Leiden University Medical Center. Primary endpoint: Change in myocardial perfusion. Started Dec 2010; status: recruiting.
02
Drugs
autologous bone marrow-derived mononuclear cell
03
Conditions
angina pectoriscardiac ischemia
Beyond the preview
Go deeper on NL-OMON20190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20190.